Drug Profile
Interleukin-1 receptor antagonist - ImmunoPharmaceutics
Alternative Names: ImmunoPharm IL-1 receptor antagonistLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator ImmunoPharmaceutics
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Encephalitis; Gingivitis; Glomerulonephritis; Gout; Inflammation; Psoriasis; Systemic lupus erythematosus
Most Recent Events
- 26 Feb 1996 Discontinued-Preclinical for Encephalitis in USA (Unknown route)
- 26 Feb 1996 Discontinued-Preclinical for Gingivitis in USA (Unknown route)
- 26 Feb 1996 Discontinued-Preclinical for Glomerulonephritis in USA (Unknown route)